Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

867 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of atazanavir in patients with end-stage liver disease.
Guaraldi G, Cocchi S, Motta A, Ciaffi S, Codeluppi M, Bonora S, Di Benedetto F, Masetti M, Floridia M, Baroncelli S, Pinetti D, Bertolini A, Gerunda GE, Esposito R. Guaraldi G, et al. Among authors: esposito r. Infection. 2009 Jun;37(3):250-5. doi: 10.1007/s15010-008-8025-z. Epub 2009 May 26. Infection. 2009. PMID: 19471855
Pharmacokinetic interaction between Amprenavir/Ritonavir and FosAmprenavir on cyclosporine in two patients with human immunodeficiency virus infection undergoing orthotopic liver transplantation.
Guaraldi G, Cocchi S, Codeluppi M, Di Benedetto F, Bonora S, Motta A, Luzi K, Pecorari M, Gennari W, Masetti M, Gerunda GE, Esposito R. Guaraldi G, et al. Among authors: esposito r. Transplant Proc. 2006 May;38(4):1138-40. doi: 10.1016/j.transproceed.2006.02.013. Transplant Proc. 2006. PMID: 16757288
Differential dose adjustments of immunosuppressants after resuming boosted versus unboosted HIV-protease inhibitors postliver transplant.
Guaraldi G, Cocchi S, Motta A, Ciaffi S, Conti C, Codeluppi M, Bonora S, Zona S, Di Benedetto F, Pinetti D, D'Avolio A, Bertolini A, Esposito R. Guaraldi G, et al. Among authors: esposito r. Am J Transplant. 2009 Oct;9(10):2429-34. doi: 10.1111/j.1600-6143.2009.02778.x. Epub 2009 Jul 28. Am J Transplant. 2009. PMID: 19656133 Free article.
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease.
Guaraldi G, Cocchi S, Motta A, Ciaffi S, Codeluppi M, Bonora S, Di Benedetto F, Masetti M, Floridia M, Baroncelli S, Pinetti D, D'Avolio A, Bertolini A, Esposito R. Guaraldi G, et al. Among authors: esposito r. J Antimicrob Chemother. 2008 Dec;62(6):1356-64. doi: 10.1093/jac/dkn383. Epub 2008 Sep 5. J Antimicrob Chemother. 2008. PMID: 18776190 Clinical Trial.
Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of Quantiferon TB GOLD results in the transplant setting: a case report.
Codeluppi M, Cocchi S, Guaraldi G, Di Benedetto F, De Ruvo N, Meacci M, Meccugni B, Esposito R, Gerunda GE. Codeluppi M, et al. Among authors: esposito r. Transplant Proc. 2006 May;38(4):1083-5. doi: 10.1016/j.transproceed.2006.02.012. Transplant Proc. 2006. PMID: 16757271
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts.
Torti C, Lapadula G, Antinori A, Quirino T, Maserati R, Castelnuovo F, Maggiolo F, De Luca A, Paraninfo G, Antonucci F, Migliorino G, Lazzarin A, Di Perri G, Rizzardini G, Esposito R, Carosi G. Torti C, et al. Among authors: esposito r. Infection. 2009 Jun;37(3):244-9. doi: 10.1007/s15010-008-8010-6. Epub 2009 May 26. Infection. 2009. PMID: 19471856
867 results